The Ordinary didn't enter skincare — it rewired it. By stripping away the theatre and putting active concentrations front and centre, DECIEM built a brand that speaks in percentages, not promises. No celebrity faces. No inflated markups. Just clinically-studied ingredients at prices that keep the conversation honest.
Every formula is built around a named active at a stated percentage. Niacinamide 10%. Retinol 1%. Ascorbic Acid 23%. There's no proprietary blend hiding behind a trademark. The label tells you exactly what's inside and how much of it — a level of disclosure that remains uncommon in prestige skincare.
Radical TransparencyMost core products land between $6 and $17. The flagship Niacinamide 10% + Zinc 1% retails for around $6 — a concentration that competitor brands often price at three to five times higher. The brand's positioning as a "price disruptor" isn't marketing language; it's the operating model.
Accessible ScienceNo fragrance suites masking actives. No celebrity endorsement budgets baked into the unit cost. The Ordinary's packaging is deliberately clinical — frosted glass, white labels, monospaced type. The brand has described itself as "faceless," letting formulation rather than persona carry the relationship.
Formulation Over FluffThe "Prep, Treat, Seal" framework encourages users to build a regimen from individual actives rather than committing to a fixed kit. This modularity suits skincare consumers who want to target specific concerns — oil control, texture, pigmentation, fine lines — without paying for steps they don't need.
Personalised RegimensNiacinamide, retinoids, alpha hydroxy acids, vitamin C derivatives, hyaluronic acid — the actives The Ordinary centres its range on are among the most extensively studied in dermatological literature. The brand's concentrations generally sit within ranges that clinical research has examined.
Clinical LiteratureFrom Sephora and Ulta to Amazon and direct-to-consumer, The Ordinary has expanded into channels that its core Gen Z and millennial audience already uses. The 2025 Amazon launch was framed explicitly around convenience for an existing customer base rather than audience acquisition.
Channel FluencyDECIEM holds the Leaping Bunny stamp of approval — no animal testing at any stage of ingredient or product development.
The Ordinary, The Chemistry Brand, and HIF are certified vegan by PETA. No animal-derived ingredients.
Retail partners including Brown Thomas and Arnotts classify The Ordinary under their Sustainable Edit programmes.
Founded and headquartered in Canada. Acquired by The Estée Lauder Companies in 2021, operating as an independent brand within the group.
| Dimension | The Ordinary | The Inkey List | Paula's Choice | CeraVe | La Roche-Posay |
|---|---|---|---|---|---|
| Positioning | Clinical actives, radical price transparency | Simplified actives, beginner-friendly | Research-driven, cosmetically elegant | Dermatologist-developed, barrier-focused | Dermocosmetic, sensitive-skin heritage |
| Price Band (Core) | $6–$17 | $8–$15 | $30–$60 | $15–$25 | $20–$40 |
| Hero Active | Niacinamide 10% + Zinc 1% | Hyaluronic Acid | 2% BHA Liquid Exfoliant | Ceramides + Hyaluronic Acid | Thermal Spring Water + Niacinamide |
| Formulation Philosophy | Single-hero actives, layered by user | Accessible single actives | Multi-ingredient, balanced systems | Barrier-repair centred | Minimal, tolerance-tested |
| Transparency Level | Exact percentages on front label | Percentages stated on packaging | Key actives listed, percentages noted | Actives listed, exact % not always stated | Actives listed, exact % not always stated |
| Cruelty-Free | ✓ Leaping Bunny + PETA Vegan | ✓ Leaping Bunny | ✗ (sells in mainland China) | ✗ (sells in mainland China) | ✗ (sells in mainland China) |
| Primary Audience | Gen Z & millennials, ingredient-literate | Skincare beginners, budget-conscious | Experienced skincare users, 30+ | Broad, dermatologist-recommended | Sensitive-skin consumers, all ages |
| Sephora Presence | Top 3 skincare brand, ~16.5% share in some analyses | Strong, but smaller footprint | Present, premium tier | Limited | Limited |
| Key Advantage | Price-per-active-concentration ratio | Entry-point simplicity | Formulation sophistication | Barrier science credibility | Sensitive-skin safety profile |
| Trade-off | High concentrations can irritate sensitive or reactive skin | Fewer high-strength options | Higher cost per millilitre | Less emphasis on trending actives | Narrower active selection |
The Ordinary's primary demographic skews 18–30, with a notable concentration in the 18–23 and 24–30 brackets. This group values ingredient literacy, price-to-performance ratios, and brands that don't feel like they're talking down to them.
The brand has been actively broadening its reach. Estée Lauder's 2026 fiscal reporting attributes The Ordinary's net sales growth to "targeted expanded consumer reach" and the success of the Multi-Peptide Serum for Hair Density — signalling a move into adjacent categories and older demographics.
Niacinamide 10% + Zinc 1% is the default entry point for oily and blemish-prone skin — it targets excess sebum, visible pores, and post-blemish marks. Salicylic Acid 2% can be layered for deeper pore clearing. The brand's own regimen builder positions these as the "treat" step in a prep–treat–seal sequence.
Retinol in Squalane (available in 0.2%, 0.5%, and 1%) and the Granactive Retinoid range offer a graduated approach to cell turnover and fine-line reduction. Lactic Acid 10% and Mandelic Acid 10% provide gentler exfoliation options for those who find glycolic acid too aggressive.
Hyaluronic Acid 2% + B5 and Natural Moisturizing Factors + HA form the hydration backbone. These are designed to be layered over actives, not instead of them — the "seal" step that locks in the treatment below. Squalane Cleanser handles the prep stage without stripping.
The Multi-Peptide Serum for Hair Density has become a breakout performer for DECIEM, cited in Estée Lauder's earnings as a key driver of The Ordinary's net sales growth. It applies the same peptide-forward, evidence-anchored logic to scalp care.
Ascorbyl Glucoside Solution 12%, Ascorbic Acid 8% + Alpha Arbutin 2%, and Azelaic Acid Suspension 10% offer multiple pathways to address dark spots and uneven tone. Azelaic Acid in particular carries dermatological support for both acne and post-inflammatory hyperpigmentation.
The AHA 30% + BHA 2% Peeling Solution is a weekly-use exfoliating treatment — a high-concentration acid blend designed for experienced users who want a more intensive resurfacing step. It sits outside the daily regimen and requires sun-protection discipline.
The Ordinary's Niacinamide 10% + Zinc 1% is my number one recommendation for oily and combination skin. It's affordable and works well across skin types — for the price, nothing else comes close on a per-active basis.
The Ordinary stands out because it offers skincare at accessible prices with clear labeling and transparent ingredient lists. Most of the line features one hero ingredient per product, which makes it easy to understand exactly what you're applying and why.
Azelaic Acid Suspension 10% is a strong choice for acne-prone skin — azelaic acid has monograph-level support for acne, and this formulation carries it at an effective concentration. It's one of the few accessible options at this strength.
The Retinol 0.5% in Squalane is a favourite among dermatologists and editors alike because it's affordable, gentle, and hydrates while promoting cell turnover. It's a well-considered entry point for retinoid users who don't want to spend $80 on a first bottle.
US skincare consumers have increasingly gravitated toward brands that can demonstrate value without asking them to choose between cost and credibility. The Ordinary's core range — most bestsellers under $17 — sits squarely in that gap. In a market where prestige serums routinely cross $60, a $6 niacinamide at 10% concentration reads as a rational purchase, not a compromise.
The US regulatory environment requires ingredient lists but does not compel brands to disclose exact active concentrations on the front of the pack. The Ordinary does this voluntarily. For American consumers who have learned to read labels through the "skinfluencer" ecosystem, that disclosure is a trust signal that few competitors replicate at the same price point.
The 2025 Amazon launch was explicitly framed around convenience for The Ordinary's core consumer. Amazon is the most accessible retail platform in the US, and The Ordinary's decision to meet its audience there — rather than insisting on a prestige-only distribution model — reflects an understanding of how American consumers actually shop for skincare.